Congenital hyperinsulinism
Gene: CACNA1CEnsemblGeneIds (GRCh38): ENSG00000151067
EnsemblGeneIds (GRCh37): ENSG00000151067
OMIM: 114205, Gene2Phenotype
CACNA1C is in 10 panels
3 reviews
Arina Puzriakova (Genomics England Curator)
The rating of this gene has been updated to Green and the mode of inheritance set to 'MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown' following NHS Genomic Medicine Service approval.Created: 31 Jan 2023, 4:38 p.m. | Last Modified: 31 Jan 2023, 4:38 p.m.
Panel Version: 2.32
Sarah Leigh (Genomics England Curator)
Comment on list classification: There is enough evidence for this gene to be rated GREEN at the next major review.Created: 27 Sep 2022, 11:42 a.m. | Last Modified: 27 Sep 2022, 11:42 a.m.
Panel Version: 2.21
Associated with in OMIM and as definitive Gen2Phen gene for Timothy syndrome (OMIM:601005). At least two CACNA1C variants have been reported in numerous cases of Timothy syndrome.
PMID: 35897673 reports novel heterozygous CACNA1C variant in a patient with congenital hyperinsulinism (CHI), which appears to have gain-of-function and loss-of-function effects at the electrophysiological level, explaining the hyperinsulinism and resulting hypoglycemia in the patient reported. It appeared that c.1679T>C, p.L566P (NM_000719.6) reported in this patient has a minor effects on the cardiac action potential in an in silico model, in contrast to c.1216G>T, p.G406R (NM_000719.6) which is associated with the Long QT in Timothy syndrome (OMIM:601005). Therefore the authors conclude that this represents a novel congeital non-syndromic hyperinsulinism.
Hypoglycemia is also seen in Timothy syndrome patients with c.1216G>T, p.G406R (Table S3, PMID: 35897673), it would therefore be appropriate to screen other patients with hyperinsulinism / hypoglycemia for CACNA1C variants.Created: 27 Sep 2022, 11:41 a.m. | Last Modified: 27 Sep 2022, 11:41 a.m.
Panel Version: 2.20
Comment on mode of pathogenicity: In vitro studies show that c.1679T>C, p.Leu566Pro (NM_000719.6) appears to have loss-of-function effects by altering current amplitudes in mutant channels and a gain-of-function effect by slowing the voltage-dependent inactivation (PMID: 35897673).Created: 27 Sep 2022, 10:36 a.m. | Last Modified: 27 Sep 2022, 10:36 a.m.
Panel Version: 2.19
Eleanor Williams (Genomics England Curator)
Review on behalf of Sophie Muir from the Timothy Syndrome Alliance (TSA). Kummer S, Rinn S, Seemann G, Bachmann N, Timothy K, Thornton PS, Pillekamp F, Mayatepek E, Bergmann C, Meissner T, Decher N. Hyperinsulinemic Hypoglycemia Associated with a CaV1.2 Variant with Mixed Gain- and Loss-of-Function Effects.International Journal of Molecular Sciences. 2022; 23(15):8097. https://doi.org/10.3390/ijms23158097.Created: 14 Sep 2022, 4:39 p.m. | Last Modified: 14 Sep 2022, 4:39 p.m.
Panel Version: 2.12
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Publications
Details
- Mode of Inheritance
- MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
- Sources
-
- NHS GMS
- Expert Review Green
- Expert review
- Phenotypes
-
- non-syndromic congeital hyperinsulinism
- Timothy syndrome, OMIM:601005
- Timothy syndrome, MONDO:0010979
- CACNA1C-related disorder
- OMIM
- 114205
- Clinvar variants
- Variants in CACNA1C
- Penetrance
- None
- Publications
- Mode of Pathogenicity
- Other
- Panels with this gene
History Filter Activity
Set Phenotypes
Eleanor Williams (Genomics England Curator)Phenotypes for gene: CACNA1C were changed from non-syndromic congeital hyperinsulinism; Timothy syndrome, OMIM:601005; Timothy syndrome, MONDO:0010979 to non-syndromic congeital hyperinsulinism; Timothy syndrome, OMIM:601005; Timothy syndrome, MONDO:0010979; CACNA1C-related disorder
Removed Tag, Removed Tag, Removed Tag
Arina Puzriakova (Genomics England Curator)Tag Q3_22_rating was removed from gene: CACNA1C. Tag Q3_22_MOI was removed from gene: CACNA1C. Tag Q3_22_NHS_review was removed from gene: CACNA1C.
Added New Source, Added New Source, Status Update
Arina Puzriakova (Genomics England Curator)Source Expert Review Green was added to CACNA1C. Source NHS GMS was added to CACNA1C. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)
Added Tag
Sarah Leigh (Genomics England Curator)Tag Q3_22_MOI tag was added to gene: CACNA1C.
Added Tag, Added Tag
Sarah Leigh (Genomics England Curator)Tag Q3_22_rating tag was added to gene: CACNA1C. Tag Q3_22_NHS_review tag was added to gene: CACNA1C.
Entity classified by Genomics England curator
Sarah Leigh (Genomics England Curator)Gene: cacna1c has been classified as Amber List (Moderate Evidence).
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for gene: CACNA1C were changed from non-syndromic congeital hyperinsulinism to non-syndromic congeital hyperinsulinism; Timothy syndrome, OMIM:601005; Timothy syndrome, MONDO:0010979
Set mode of pathogenicity
Sarah Leigh (Genomics England Curator)Mode of pathogenicity for gene: CACNA1C was changed from to Other
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for gene: CACNA1C were changed from to non-syndromic congeital hyperinsulinism
Set publications
Sarah Leigh (Genomics England Curator)Publications for gene: CACNA1C were set to
Set mode of inheritance
Sarah Leigh (Genomics England Curator)Mode of inheritance for gene: CACNA1C was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Created, Added New Source, Set mode of inheritance
Eleanor Williams (Genomics England Curator)gene: CACNA1C was added gene: CACNA1C was added to Congenital hyperinsulinism. Sources: Expert review Mode of inheritance for gene: CACNA1C was set to